Stay updated on BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial
Sign up to get notified when there's something new on the BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial page.

Latest updates to the BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a consolidated 'Locations' section listing sites in AZ, FL, IN, OK, TX, Alberta, Newfoundland and Labrador, and Quebec, and removed the separate state/province location subsections. Updated the revision to v3.3.3 and removed the HHS Vulnerability Disclosure entry as well as the v3.3.2 note.SummaryDifference0.8%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a note in Publications indicating that entries are automatically filled from PubMed and may not pertain to the study. Updated the Revision version from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check43 days agoChange DetectedThe government funding notice banner was removed. All other study details and contact information remain unchanged.SummaryDifference0.3%

- Check64 days agoChange DetectedThe changes appear to be administrative updates to the study record (e.g., last update date) with no modifications to core content, eligibility criteria, or the list of participating sites. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedSummary of changes: added new data transparency statements and reference to a data-sharing framework; removed several older, specific document links and time-frame details.SummaryDifference8%

- Check87 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%

Stay in the know with updates to BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 655130 in Atopic Eczema: Efficacy and Tolerability Clinical Trial page.